Top Markets
#1 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +33.55%
#2 Bitcoin Cash Bitcoin Cash +33.37%
#3 Audiera Audiera +31.77%
#4 Fabric Protocol Fabric Protocol +30.62%
#5 Tutorial Tutorial +28.68%
#6 GALA GALA +28.51%
#7 TROLL TROLL +28.24%
#8 Arowana Arowana +27.65%
#9 Useless Coin Useless Coin +26.71%
#10 Ethena Staked ENA Ethena Staked ENA +26.37%
Coin of the day
Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Classement en actions #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Prix de l'action
$0.95011029
Dernière synchronisation: 2023-06-28
Capitalisation boursière
$57.72M
Changement (1 jour)
8.53%
Changement (1 an)
0.00%
Pays
FR
Échange ERYTECH Pharma S.A. (ERYP)

Catégorie

Healthcare
Ratio P/B pour ERYTECH Pharma S.A. (ERYP)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de ERYTECH Pharma S.A., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour ERYTECH Pharma S.A. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH